Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Aug 04, 2022 8:25pm
277 Views
Post# 34872852

I agree with Kwdelux 100%....Pharma is not buying, but could

I agree with Kwdelux 100%....Pharma is not buying, but couldI agree with KW delux analysis 100%.
Big pharma is not in the business of stock manipulation.
If they decied to "buy" onc it will be an an all-in offer.
For them to Quietly accumulate? not their bag.
A board decisiion would be made and negotiations would start.

That -said, not is not beyond institutions to aquire on the wisper of news etc.
All..good data and indicatons,
The 3 ou of 3 patents responding with a 50% shrinkage is awsome!
Yes only 3, but they have quickly advanced to full enrolment.
All open lable & all real time.
Roche will know sson enoghif they want to fund a phase 3 partnership.


<< Previous
Bullboard Posts
Next >>